Garlind A - Search Results

1

White matter lesions and soluble interleukin-1 receptor type II in CSF from demented and non-demented subjects.

Bronge L, Wahlund LO, Brauner A, Basun H, Garlind A. Bronge L, et al. Among authors: garlind a. Neurochem Int. 2002 Oct;41(4):217-22. doi: 10.1016/s0197-0186(02)00025-6. Neurochem Int. 2002. PMID: 12106772

2

Soluble interleukin-1 receptor type II, IL-18 and caspase-1 in mild cognitive impairment and severe Alzheimer's disease.

Lindberg C, Chromek M, Ahrengart L, Brauner A, Schultzberg M, Garlind A. Lindberg C, et al. Among authors: garlind a. Neurochem Int. 2005 Jun;46(7):551-7. doi: 10.1016/j.neuint.2005.01.004. Neurochem Int. 2005. PMID: 15843049

3

Soluble interleukin-1 receptor type II levels are elevated in cerebrospinal fluid in Alzheimer's disease patients.

Garlind A, Brauner A, Höjeberg B, Basun H, Schultzberg M. Garlind A, et al. Brain Res. 1999 Apr 24;826(1):112-6. doi: 10.1016/s0006-8993(99)01092-6. Brain Res. 1999. PMID: 10216202

4

Omega-3 fatty acid treatment in 174 patients with mild to moderate Alzheimer disease: OmegAD study: a randomized double-blind trial.

Freund-Levi Y, Eriksdotter-Jönhagen M, Cederholm T, Basun H, Faxén-Irving G, Garlind A, Vedin I, Vessby B, Wahlund LO, Palmblad J. Freund-Levi Y, et al. Among authors: garlind a. Arch Neurol. 2006 Oct;63(10):1402-8. doi: 10.1001/archneur.63.10.1402. Arch Neurol. 2006. PMID: 17030655 Clinical Trial.

5

Omega-3 supplementation in mild to moderate Alzheimer's disease: effects on neuropsychiatric symptoms.

Freund-Levi Y, Basun H, Cederholm T, Faxén-Irving G, Garlind A, Grut M, Vedin I, Palmblad J, Wahlund LO, Eriksdotter-Jönhagen M. Freund-Levi Y, et al. Among authors: garlind a. Int J Geriatr Psychiatry. 2008 Feb;23(2):161-9. doi: 10.1002/gps.1857. Int J Geriatr Psychiatry. 2008. PMID: 17582225 Clinical Trial.

6

Effects of DHA-rich n-3 fatty acid supplementation on gene expression in blood mononuclear leukocytes: the OmegAD study.

Vedin I, Cederholm T, Freund-Levi Y, Basun H, Garlind A, Irving GF, Eriksdotter-Jönhagen M, Wahlund LO, Dahlman I, Palmblad J. Vedin I, et al. Among authors: garlind a. PLoS One. 2012;7(4):e35425. doi: 10.1371/journal.pone.0035425. Epub 2012 Apr 24. PLoS One. 2012. PMID: 22545106 Free PMC article. Clinical Trial.

7

Effects of docosahexaenoic acid-rich n-3 fatty acid supplementation on cytokine release from blood mononuclear leukocytes: the OmegAD study.

Vedin I, Cederholm T, Freund Levi Y, Basun H, Garlind A, Faxén Irving G, Jönhagen ME, Vessby B, Wahlund LO, Palmblad J. Vedin I, et al. Among authors: garlind a. Am J Clin Nutr. 2008 Jun;87(6):1616-22. doi: 10.1093/ajcn/87.6.1616. Am J Clin Nutr. 2008. PMID: 18541548 Free article. Clinical Trial.

8

[International Alzheimer research--from management to molecular biology].

Basun H, Garlind A, Lannfelt L. Basun H, et al. Among authors: garlind a. Nord Med. 1993;108(1):18-9. Nord Med. 1993. PMID: 8424050 Swedish. No abstract available.

9

Characterization of [3H]inositol 1,4,5-trisphosphate binding sites in human temporal cortical and cerebellar membranes.

Garlind A, Cowburn RF, Fowler CJ. Garlind A, et al. Neurochem Int. 1994 Jan;24(1):73-80. doi: 10.1016/0197-0186(94)90131-7. Neurochem Int. 1994. PMID: 8130738

10

Characterization and regional distribution of adenylyl cyclase activity from human brain.

Cowburn RF, Garlind A, O'Neill C, Alafuzoff I, Winblad B, Fowler CJ. Cowburn RF, et al. Among authors: garlind a. Neurochem Int. 1991;18(3):389-98. doi: 10.1016/0197-0186(91)90171-9. Neurochem Int. 1991. PMID: 20504716

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

30 results

Search Page

Filters